Protein misfolding in neurodegenerative diseases: implications and strategies

P Sweeney, H Park, M Baumann, J Dunlop… - … neurodegeneration, 2017 - Springer
… , misfolded proteins are either degraded or refolded correctly by chaperone proteins that are
involved in protein folding … Indeed, it is now believed that many, if not all, proteins can form …

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

J Gandhi, AC Antonelli, A Afridi, S Vatsia… - Reviews in the …, 2019 - degruyter.com
… fundamentals of proteins; the process of protein folding in the … role of protein folding in
neurodegenerative diseases such as … , is to combat the denaturing effects of these stress-inducing …

Therapeutic strategies against protein misfolding in neurodegenerative diseases

C Soto, Z Martin - Expert Opinion on Drug Discovery, 2009 - Taylor & Francis
… (eg, Alzhemed trial) or serious side effects (eg, the vaccination trial), we believe that prevention
and removal of misfolded aggregates is the most promising strategy to treat ND. It is likely …

Unfolding the role of protein misfolding in neurodegenerative diseases

C Soto - Nature Reviews Neuroscience, 2003 - nature.com
… future research in this field will result in exciting new discoveries that might impact other areas
of biology. … of different therapeutic strategies to arrest protein misfolding and aggregation. …

Protein misfolding in neurodegenerative diseases

EI Agorogiannis, GI Agorogiannis… - Neuropathology and …, 2004 - Wiley Online Library
… treatment of neurodegenerative diseases and protein-misfolding ailments The implications of
… These treatment strategies should be directed towards blocking the activity of the causative …

Protein aggregation landscape in neurodegenerative diseases: Clinical relevance and future applications

N Candelise, S Scaricamazza, I Salvatori… - International journal of …, 2021 - mdpi.com
Protein folding is a tightly regulated process that relies … protein 43 (TDP-43). As a caveat,
we will focus on the wild-type sequence of these proteins, as most neurodegenerative diseases

Novel therapeutic strategies for the treatment of protein-misfolding diseases

JC Rochet - Expert reviews in molecular medicine, 2007 - cambridge.org
disease, amyotrophic lateral sclerosis and type II diabetes) are characterised by protein
misfolding … the development of therapeutic strategies targeting these diseases. Three promising …

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

A Ciechanover, YT Kwon - Experimental & molecular medicine, 2015 - nature.com
… The accumulation of protease-resistant misfolded and aggregated proteins is a common
mechanism underlying protein misfolding disorders, including neurodegenerative

Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

C Soto, S Pritzkow - Nature neuroscience, 2018 - nature.com
strategies for treatment and diagnosis. In this Review, we provide a critical discussion of the
role of protein misfolding … We will also describe the molecular basis and implications for prion…

A review on protein misfolding, aggregation and strategies to prevent related ailments

TN Shamsi, T Athar, R Parveen, S Fatima - International journal of …, 2017 - Elsevier
… of protein misfolding, aggregation inconsideration of neurodegenerative diseases. The
main … NPs’ effect on protein aggregation in neurodegenerative diseases involving amyloid-beta …